Biopharmaceutical

The Latest

  • CStone Shares Skyrocket Following $480 Million Pfizer Deal
    Pfizer
    CStone Pharmaceuticals stock price jumped by as much as 40 percent after it announced a deal with Pfizer worth an estimated $480 million.